Webinars

NOV 15, 2018 12:00 PM PST

Better Knowledge, Better Care: Precision Medicine for Any Cancer, Any Assay, on Your Platform

Presented at: Clinical Diagnostics & Research 2018

Sponsored by: QIAGEN

Speakers

Raed Samara, PhD
Senior Global Product Manager, QIAGEN
Biography
Raed Samara, PhD is a Global Product Manager for NGS technologies at QIAGEN, with a focus on pre-analytics and targeted enrichment. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.
Dan Richards, PhD
Vice President, Biomedical Informatics, QIAGEN
Biography
Dan Richards is Vice President, Biomedical Informatics at QIAGEN, where he focuses on the automated interpretation of molecular variation in the context of current clinical evidence. Dan earned his Ph.D. in Human Genetics from Stanford University and co-founded Ingenuity Systems, whose analysis applications and manually-curated knowledge base of peer-reviewed scientific literature are used by scientists and clinicians worldwide to interpret genomic data in the context of current biomedical knowledge.

Abstract

QIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present a lung cancer case study to show how QIAGEN Clinical Insight (QCI™) allows you to optimize and scale your pipeline for the clinical interpretation of genetic variants—from sequence data to report sign-off—without sacrificing accuracy or utility. QCI Interpret is a flexible clinical decision support suite that is compatible with any NGS platform, running any assay, targeting somatic, hereditary, hematological or childhood cancers.

Show Resources

You May Also Like

OCT 08, 2020 7:00 AM PDT

C.E. CREDITS

OCT 08, 2020 7:00 AM PDT

Protect your cells with proper pipetting - How liquid handling...

DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...

DEC 02, 2020 8:00 AM PST

C.E. CREDITS

DEC 02, 2020 8:00 AM PST

Optimize your bioprocess - From shaker to bioreactor

DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...

AUG 25, 2020 8:00 AM PDT

C.E. CREDITS

AUG 25, 2020 8:00 AM PDT

How LV and AAV Transfection Platforms will Shape the Future of...

DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...

NOV 18, 2020 8:00 AM PST

C.E. CREDITS

NOV 18, 2020 8:00 AM PST

Whole-organ mapping using AI and light sheet microscopy

DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...

NOV 16, 2020 8:00 AM PST

C.E. CREDITS

NOV 16, 2020 8:00 AM PST

Targeted single-cell RNA sequencing enables genome-scale CRISPR...

Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...

Speaker: Wieland Keilholz, Ph.D. , Pawel Zajac, Ph.D. , Dr. Tilmann Buerckstuemmer

Sponsored By: Illumina

SEP 10, 2020 9:00 AM PDT

C.E. CREDITS

SEP 10, 2020 9:00 AM PDT

An Insider's Look: How One Parameter Can Optimize Key Phases of...

Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...